Chen Schor Insider Profile
4 Followers
Chen Schor, President & CEO, Director at Adicet Bio, holds 15.51K shares in Karyopharm Therapeutics (Ticker: KPTI), holds 12.88K shares in Adicet Bio (Ticker: ACET), holds 125.56K shares in Brainstorm Cell Therapeutics (Ticker: BCLI).
Chen Schor Adicet Bio (ACET)President & CEO, Director
Adicet Bio (ACET)
President & CEO, Director
Ranked #78,141 out of 108,699 Corporate Insiders
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-13.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Chen Schor holds in companies
Most Profitable Insider Trade
The most profitable trade made by Chen Schor
Chen Schor's Trading History
Adicet Bio
Jan 27, 2026
President & CEO, Director
Uninformative Sell
14.81K
$118.32K
Karyopharm Therapeutics
May 26, 2026
Director
Uninformative Buy
―
$30.40K
Madrigal Pharmaceuticals
Jun 08, 2015
President & CEO, Director
Uninformative Buy
―
$155.02M
Brainstorm Cell Therapeutics
Dec 21, 2018
Director
Uninformative Buy
―
$123.05K
List of latest transactions for each holding click on a transaction to see Chen Schor's performance on stock
You May Also Like
Chen Schor insider profile FAQ
What is the percentage of profitable transactions made by Chen Schor?
The percentage of profitable transactions made by Chen Schor is 0%.
What is the average return per transaction made by Chen Schor?
The average return per transaction made by Chen Schor is -13.60%.
What stocks does Chen Schor hold?
Chen Schor holds: ACET, KPTI, MDGL, BCLI stocks.
What was Chen Schor’s latest transaction?
Chen Schor latest transaction was an Uninformative Buy of ―.
What was Chen Schor's most profitable transaction?
Chen Schor’s most profitable transaction was an Informative Buy of ACET stock on October 2, 2023. The return on the trade was 0.00%.
What is Chen Schor's role in Adicet Bio?
Chen Schor's role in Adicet Bio is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.